Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 2/20 | 0.40 |
| ▸ | CTSB | P07858 | 9/20 | 0.34 |
| ▸ | CTSL | P07711 | 8/20 | 0.34 |
| ▸ | CTSS | P25774 | 8/20 | 0.34 |
| ▸ | CTSK | P43235 | 8/20 | 0.34 |
| ▸ | PREP | P48147 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13448173 | 0.79 | ACE (0.45) | ACECTSBCTSLCTSSCTSK | |
| SCHEMBL13448164 | 0.79 | ACE (0.43) | ACECTSBCTSLCTSSCTSK | |
| SCHEMBL13448383 | 0.77 | ACE (0.41) | ACECTSBCTSLCTSSCTSK | |
| SCHEMBL13448396 | 0.76 | ACE (0.44) | ACECTSBCTSLCTSSCTSK | |
| SCHEMBL13448393 | 0.76 | ACE (0.42) | ACECTSBCTSLCTSSCTSK | |
| SCHEMBL13448168 | 0.75 | ACE (0.42) | ACECTSBCTSLCTSSCTSK | |
| SCHEMBL13448379 | 0.75 | ACE (0.44) | ACECTSBCTSLCTSSCTSK | |
| SCHEMBL8279524 | 0.75 | ABCG2 (0.64) | CTSBCTSLCTSSCTSKABCG2 | |
| SCHEMBL31593075 | 0.71 | POLB (0.41) | ACEPREPMEN1USP2LMNA | |
| SCHEMBL10139037 | 0.69 | ACE (0.41) | ACECTSBCTSLCTSSCTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7683033-B2 | Inhibitors of serine proteases, particularly HCV NS3-NS4A protease | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2010-03-23 | — | — | US | disclosed |